2019
DOI: 10.3389/fmicb.2019.00539
|View full text |Cite
|
Sign up to set email alerts
|

Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review

Abstract: The acronym ESKAPE includes six nosocomial pathogens that exhibit multidrug resistance and virulence: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa , and Enterobacter spp. Persistent use of antibiotics has provoked the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) bacteria, which render even the most effective drugs ineffective. Extended spectrum β-lactamase (ESBL) a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

5
831
0
20

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 1,058 publications
(870 citation statements)
references
References 214 publications
5
831
0
20
Order By: Relevance
“…Increase in uncontrolled, irrational antibiotic use, lack of incentives, and research efforts for the development of new antibiotics resulted in antibiotic resistance worldwide [2]. ESKAPEE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., and Escherichia coli) play a prominent role in this global epidemic and are considered by the WHO as high-risk pathogens [3][4][5][6]. Alone in the EU antibiotic resistant, microbes cause reportedly disability, mortality, and increasing costs in medical care [7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…Increase in uncontrolled, irrational antibiotic use, lack of incentives, and research efforts for the development of new antibiotics resulted in antibiotic resistance worldwide [2]. ESKAPEE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., and Escherichia coli) play a prominent role in this global epidemic and are considered by the WHO as high-risk pathogens [3][4][5][6]. Alone in the EU antibiotic resistant, microbes cause reportedly disability, mortality, and increasing costs in medical care [7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…Microbial infections continue to be a problem, for humans [5], as well as for livestock and other agriculture settings [6][7][8]. Compounding this problem are newly emerging pathogenic microorganisms, in addition to re-emerging multidrug-resistant pathogens [9,10].…”
Section: Introductionmentioning
confidence: 99%
“…Recently, WHO published a list of MDR bacteria which are of critical concern [2]. Especially worrying are the Gram-negative pathogens Pseudomonas aeruginosa, Acinetobacter baumannii and several species of Enterobacteriaceae [3]. The development of carbapenem resistance in these species has led to the re-introduction of the last resort antibiotic Colistin, which was initially abandoned due to side-effects.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, the compound showed moderate toxicity against red blood cells and resistance to proteolytic degradation [18]. D2D consists of 4 cationic residues lys 1 , lys 2 , lys 5 , lys 7 and 4 hydrophobic residues 1-naphthylalanine (1-nal) 3 , phe 4 , 1-nal 6 , norleucine (nle) 8 . D2D is a full d-amino acid analog derived from a structure-activity relationship study of the peptoid D2.…”
Section: Introductionmentioning
confidence: 99%